Related references
Note: Only part of the references are listed.Functional Genomics In Vivo Reveal Metabolic Dependencies of Pancreatic Cancer Cells
Xiphias Ge Zhu et al.
CELL METABOLISM (2021)
Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer
Douglas E. Biancur et al.
CELL METABOLISM (2021)
Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast-Driven Nutritional Support and Immunosuppression
Ralph Francescone et al.
CANCER DISCOVERY (2021)
Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer
G. Aaron Hobbs et al.
CANCER DISCOVERY (2020)
Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer
Eric C. Cheung et al.
CANCER CELL (2020)
A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells
Hee Chan Yoo et al.
CELL METABOLISM (2020)
Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy
Nikita S. Sharma et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Loss of Rnf43 to accelerate KRAS-mediated neoplasia in a clinically relevant genetically engineered mouse model of pancreatic adenocarcinoma.
Abdel Nasser Hosein et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype
Nicole M. Sodir et al.
CANCER DISCOVERY (2020)
Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment
Prasenjit Dey et al.
CANCER DISCOVERY (2020)
Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment
Erin Helms et al.
Cancer Discovery (2020)
A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer Patients
Herbert J. Zeh et al.
CLINICAL CANCER RESEARCH (2020)
20,000 picometers under the OMM: diving into the vastness of mitochondrial metabolite transport
Corey N. Cunningham et al.
EMBO REPORTS (2020)
Acidic fibroblast growth factor underlies microenvironmental regulation of MYC in pancreatic cancer
Sohinee Bhattacharyya et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Cysteine depletion induces pancreatic tumor ferroptosis in mice
Michael A. Badgley et al.
SCIENCE (2020)
Nitrogen Metabolism in Cancer and Immunity
Kiran Kurmi et al.
TRENDS IN CELL BIOLOGY (2020)
Selective Alanine Transporter Utilization Creates a Targetable Metabolic niche in Pancreatic Cancer
Seth J. Parker et al.
CANCER DISCOVERY (2020)
Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
Nathiya Muthalagu et al.
CANCER DISCOVERY (2020)
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
Keisuke Yamamoto et al.
NATURE (2020)
The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities
Won Jin Ho et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Pancreatic cancer stroma: an update on therapeutic targeting strategies
Abdel N. Hosein et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Mitochondrial Metabolism as a Target for Cancer Therapy
Karthik Vasan et al.
CELL METABOLISM (2020)
Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma
Allison N. Lau et al.
ELIFE (2020)
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
Min-Hee Oh et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer
Maria Victoria Recouvreux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
SOAT1 promotes mevalonate pathway dependency in pancreatic cancer
Tobiloba E. Oni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Molecular Targeting of a BRAF Mutation in Pancreatic Ductal Adenocarcinoma: Case Report and Literature Review
An-Katrien Seghers et al.
TARGETED ONCOLOGY (2020)
The Complex Interplay between Antioxidants and ROS in Cancer
Isaac S. Harris et al.
TRENDS IN CELL BIOLOGY (2020)
Emerging Mechanisms and Disease Relevance of Ferroptosis
Brent R. Stockwell et al.
TRENDS IN CELL BIOLOGY (2020)
Respiratory Supercomplexes Promote Mitochondrial Efficiency and Growth in Severely Hypoxic Pancreatic Cancer
Kate E. R. Hollinshead et al.
CELL REPORTS (2020)
Neurons Release Serine to Support mRNA Translation in Pancreatic Cancer
Robert S. Banh et al.
CELL (2020)
KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth
Susanna Raho et al.
NATURE METABOLISM (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
Gerta Hoxhaj et al.
NATURE REVIEWS CANCER (2020)
Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer Stroma
Paloma E. Garcia et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases
Ashton A. Connor et al.
CANCER CELL (2019)
Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer
Christopher J. Halbrook et al.
CELL METABOLISM (2019)
Autophagy modulates lipid metabolism to maintain metabolic flexibility for Lkb1-deficient Kras-driven lung tumorigenesis
Vrushank Bhatt et al.
GENES & DEVELOPMENT (2019)
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer
Wantong Yao et al.
NATURE (2019)
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
Kirsten L. Bryant et al.
NATURE MEDICINE (2019)
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers
Conan G. Kinsey et al.
NATURE MEDICINE (2019)
MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival
Chih-Shia Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion
Irmina A. Elliott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A Stromal Lysolipid-Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression
Francesca R. Auciello et al.
CANCER DISCOVERY (2019)
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring
Yu Shi et al.
NATURE (2019)
Tumor Neurobiology and the War of Nerves in Cancer
Sam Faulkner et al.
CANCER DISCOVERY (2019)
Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability
Mark R. Sullivan et al.
ELIFE (2019)
Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer A Phase 2 Randomized Clinical Trial
Thomas B. Karasic et al.
JAMA ONCOLOGY (2019)
Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer
Neha M. Akella et al.
BMC BIOLOGY (2019)
Genetic Ablation of the Cystine Transporter xCT in PDAC Cells Inhibits mTORC1, Growth, Survival, and Tumor Formation via Nutrient and Oxidative Stresses
Boutaina Daher et al.
CANCER RESEARCH (2019)
Cancer modeling meets human organoid technology
David Tuveson et al.
SCIENCE (2019)
Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer
Devon R. Blake et al.
SCIENCE SIGNALING (2019)
Competition for nutrients and its role in controlling immune responses
Nidhi Kedia-Mehta et al.
NATURE COMMUNICATIONS (2019)
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Erick Riquelme et al.
CELL (2019)
EGFR-Pak Signaling Selectively Regulates Glutamine Deprivation-Induced Macropinocytosis
Szu-Wei Lee et al.
DEVELOPMENTAL CELL (2019)
A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas
Philip A. Philip et al.
FUTURE ONCOLOGY (2019)
α-Ketoglutarate links p53 to cell fate during tumour suppression
John P. Morris et al.
NATURE (2019)
Targeting Autophagy in Cancer: Recent Advances and Future Directions
Ravi K. Amaravadi et al.
CANCER DISCOVERY (2019)
T Cell Activation Depends on Extracellular Alanine
Noga Ron-Harel et al.
CELL REPORTS (2019)
Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth
Sarbajeet Nagdas et al.
CELL REPORTS (2019)
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D. Leone et al.
SCIENCE (2019)
Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism
Alex J. Bott et al.
CELL REPORTS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethality
Shuichi Watanabe et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
MITO-Tag Mice enable rapid isolation and multimodal profiling of mitochondria from specific cell types in vivo
Erol C. Bayraktar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
KRAS4A directly regulates hexokinase 1
Caroline R. Amendola et al.
NATURE (2019)
Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis
Craig Ramirez et al.
NATURE (2019)
β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer
Bernhard W. Renz et al.
CANCER CELL (2018)
Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism
Krushna C. Patra et al.
NATURE CELL BIOLOGY (2018)
GNAS shifts metabolism in pancreatic cancer
Pablo E. Hollstein et al.
NATURE CELL BIOLOGY (2018)
The multifaceted contributions of mitochondria to cellular metabolism
Jessica B. Spinelli et al.
NATURE CELL BIOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases
Arnaud Pommier et al.
SCIENCE (2018)
Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and nonautonomous Mechanisms
Annan Yang et al.
CANCER DISCOVERY (2018)
We're Not DON Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine
Kathryn M. Lemberg et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Naiara Santana-Codina et al.
NATURE COMMUNICATIONS (2018)
LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
Christian Bressy et al.
CANCER RESEARCH (2018)
Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth
Shiro L. Cramer et al.
NATURE MEDICINE (2017)
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial
Angela Alistar et al.
LANCET ONCOLOGY (2017)
Nutrient acquisition strategies of mammalian cells
Wilhelm Palm et al.
NATURE (2017)
Glucose feeds the TCA cycle via circulating lactate
Sheng Hui et al.
NATURE (2017)
Rapid immunopurification of mitochondria for metabolite profiling and absolute quantification of matrix metabolites
Walter W. Chen et al.
NATURE PROTOCOLS (2017)
Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes
Monther Abu-Remaileh et al.
SCIENCE (2017)
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T. Geller et al.
SCIENCE (2017)
Metabolic Interactions in the Tumor Microenvironment
Costas A. Lyssiotis et al.
TRENDS IN CELL BIOLOGY (2017)
Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions
Orianne Olivares et al.
NATURE COMMUNICATIONS (2017)
Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism
Douglas E. Biancur et al.
NATURE COMMUNICATIONS (2017)
Lactate Metabolism in Human Lung Tumors
Brandon Faubert et al.
CELL (2017)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Andrew J. Aguirre et al.
CANCER CELL (2017)
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer
Surendra K. Shukla et al.
CANCER CELL (2017)
One-carbon metabolism in cancer
Alice C. Newman et al.
BRITISH JOURNAL OF CANCER (2017)
Glutamine Metabolism in Cancer: Understanding the Heterogeneity
Ahmad A. Cluntun et al.
TRENDS IN CANCER (2017)
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer
Christopher J. Habrook et al.
CANCER CELL (2017)
Absolute Quantification of Matrix Metabolites Reveals the Dynamics of Mitochondrial Metabolism
Walter W. Chen et al.
CELL (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells
Jessie Yanxiang Guo et al.
GENES & DEVELOPMENT (2016)
Mechanisms of Selective Autophagy in Normal Physiology and Cancer
Joseph D. Mancias et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Concepts to Target MYC in Pancreatic Cancer
Matthias Wirth et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion
Cristovao M. Sousa et al.
NATURE (2016)
A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma
Thomas W. Lycan et al.
PLOS ONE (2016)
Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer
Jami L. Saloman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Serine and one-carbon metabolism in cancer
Ming Yang et al.
NATURE REVIEWS CANCER (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma
Brian A. Boone et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer
Yong Bian et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Human Pancreatic Cancer Tumors Are Nutrient Poor and Tumor Cells Actively Scavenge Extracellular Protein
Jurre J. Kamphorst et al.
CANCER RESEARCH (2015)
Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism
RushikaM. Perera et al.
NATURE (2015)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma
Fabienne Guillaumond et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up
Rushika M. Perera et al.
CANCER DISCOVERY (2015)
The Impact of Neural Invasion Severity in Gastrointestinal Malignancies A Clinicopathological Study
Florian Liebl et al.
ANNALS OF SURGERY (2014)
PI3K Regulation of RAC1 Is Required for KRAS-Induced Pancreatic Tumorigenesis in Mice
Chia-Yen C. Wu et al.
GASTROENTEROLOGY (2014)
Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110α
Romain Baer et al.
GENES & DEVELOPMENT (2014)
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Andrea Viale et al.
NATURE (2014)
Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma
Brian M. Wolpin et al.
ONCOLOGIST (2014)
The pentose phosphate pathway and cancer
Krushna C. Patra et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Autophagy Is Critical for Pancreatic Tumor Growth and Progression in Tumors with p53 Alterations
Annan Yang et al.
CANCER DISCOVERY (2014)
Mitochondrial reactive oxygen species and cancer
Lucas B. Sullivan et al.
CANCER & METABOLISM (2014)
Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses
Daniela Kenzelmann Broz et al.
GENES & DEVELOPMENT (2013)
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Cosimo Commisso et al.
NATURE (2013)
p53 status determines the role of autophagy in pancreatic tumour development
Mathias T. Rosenfeldt et al.
NATURE (2013)
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Jaekyoung Son et al.
NATURE (2013)
Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia
Yuliya Pylayeva-Gupta et al.
CANCER CELL (2012)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
The Pancreas Cancer Microenvironment
Christine Feig et al.
CLINICAL CANCER RESEARCH (2012)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Andrew V. Biankin et al.
NATURE (2012)
Metabolism of [U-13C]glucose in human brain tumors in vivo
Elizabeth A. Maher et al.
NMR IN BIOMEDICINE (2012)
A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans
Daniel K. Bricker et al.
SCIENCE (2012)
Nerve-cancer interactions in the stromal biology of pancreatic cancer
Ihsan Ekin Demir et al.
FRONTIERS IN PHYSIOLOGY (2012)
Pancreatic cancers require autophagy for tumor growth
Shenghong Yang et al.
GENES & DEVELOPMENT (2011)
Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo
Zuzana Zachar et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H+-ATPase
Roberto Zoncu et al.
SCIENCE (2011)
PTEN Is a Major Tumor Suppressor in Pancreatic Ductal Adenocarcinoma and Regulates an NF-κB-Cytokine Network
Haoqiang Ying et al.
CANCER DISCOVERY (2011)
Perineural invasion and associated pain in pancreatic cancer
Aditi A. Bapat et al.
NATURE REVIEWS CANCER (2011)
PTEN Loss Accelerates KrasG12D-Induced Pancreatic Cancer Development
Reginald Hill et al.
CANCER RESEARCH (2010)
Pancreatic Neuropathy Results in Neural Remodeling and Altered Pancreatic Innervation in Chronic Pancreatitis and Pancreatic Cancer
Gueralp Onur Ceyhan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Cancer-associated stroma fibroblasts promote pancreatic tumor progression
Rosa F. Hwang et al.
CANCER RESEARCH (2008)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects
DA Tuveson et al.
CANCER CELL (2004)
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma
AJ Aguirre et al.
GENES & DEVELOPMENT (2003)
Pancreatic tumors show high levels of hypoxia
AC Koong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Constitutive macropinocytosis in oncogene-transformed fibroblasts depends on sequential permanent activation of phosphoinositide 3-kinase and phospholipase C
M Amyere et al.
MOLECULAR BIOLOGY OF THE CELL (2000)
Share Paper
